Keyphrases
Botulinum Neurotoxin (BoNT)
100%
Intra-articular
100%
Knee Osteoarthritis
100%
Painful Knee
100%
High Dose
20%
Visual Analog Scale
20%
Patient-completed
20%
P-15
20%
Visual Analog Pain Scale
20%
Tertiary Care
20%
Western Ontario
20%
McMaster
20%
Arthritis Index
20%
Physical Therapy
10%
Patient Demographics
10%
Placebo
10%
Study Support
10%
Treatment Options
10%
Functional Impairment
10%
Adverse Effects
10%
Corticosteroids
10%
Double-blind Randomized Study
10%
Academic Medical Centers
10%
Statistical Significance
10%
Short Form 36 (SF-36)
10%
After Injection
10%
Multiple Injections
10%
Outpatient Clinic
10%
Index Score
10%
Primary Outcome Measure
10%
Serious Adverse Events
10%
Patient Global Assessment
10%
6-month Follow-up
10%
Medical Institutions
10%
Injection Therapy
10%
Symptomatic Knee Osteoarthritis
10%
Stiffness Function
10%
Unit Dose
10%
Intratympanic Corticosteroid
10%
Orthopaedic Outpatients
10%
Nursing and Health Professions
Pilot Study
100%
Knee Osteoarthritis
100%
Botulinum Toxin A
100%
Botulinum Toxin Type A
100%
Low Drug Dose
33%
Visual Analog Scale
33%
Tertiary Health Care
22%
Arthritis
22%
Drug Megadose
22%
University Hospital
11%
Outpatient Department
11%
Patient Population
11%
Rigidity
11%
Placebo
11%
Outcome Assessment
11%
Osteoarthritis
11%
Physiotherapy
11%
Adverse Event
11%
Short Form 36
11%
Functional Disease
11%
Medicine and Dentistry
Botulinum Toxin
100%
Botulinum Toxin A
100%
Knee Osteoarthritis
100%
Low Drug Dose
33%
Visual Analog Scale
33%
Drug Megadose
22%
Arthritis
22%
Tertiary Care
22%
Outcome Assessment
11%
Outpatient
11%
Orthopedics
11%
Osteoarthritis
11%
Patient Population
11%
Adverse Event
11%
Functional Disease
11%
Short Form 36
11%
Physiotherapy
11%
Unit Dose
11%
Placebo
11%
Adverse Effect
11%